Tami L. Mark

5.3k total citations
145 papers, 4.0k citations indexed

About

Tami L. Mark is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, Tami L. Mark has authored 145 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Epidemiology, 50 papers in Public Health, Environmental and Occupational Health and 50 papers in Economics and Econometrics. Recurrent topics in Tami L. Mark's work include Substance Abuse Treatment and Outcomes (48 papers), Opioid Use Disorder Treatment (44 papers) and Healthcare Policy and Management (36 papers). Tami L. Mark is often cited by papers focused on Substance Abuse Treatment and Outcomes (48 papers), Opioid Use Disorder Treatment (44 papers) and Healthcare Policy and Management (36 papers). Tami L. Mark collaborates with scholars based in United States, Canada and United Kingdom. Tami L. Mark's co-authors include Katharine R. Levit, Jeffrey A. Buck, Rita Vandivort-Warren, Rosanna M. Coffey, William J. Parish, Henry R. Kranzler, Joffre Swait́, Joan Dilonardo, Cheryl A. Kassed and Kimberly A. McGuigan and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and American Journal of Psychiatry.

In The Last Decade

Tami L. Mark

137 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tami L. Mark United States 35 1.4k 1.2k 1.2k 911 602 145 4.0k
Karen E. Lasser United States 30 817 0.6× 2.0k 1.6× 937 0.8× 1.1k 1.2× 292 0.5× 93 6.4k
Julie M. Donohue United States 39 836 0.6× 1.1k 0.9× 1.3k 1.1× 2.0k 2.1× 417 0.7× 204 5.3k
Teresa J. Hudson United States 27 442 0.3× 668 0.6× 1.1k 0.9× 350 0.4× 457 0.8× 82 3.3k
Yuhua Bao United States 29 506 0.4× 696 0.6× 1.2k 1.1× 432 0.5× 328 0.5× 112 3.1k
William B. Weeks United States 40 542 0.4× 2.2k 1.9× 862 0.7× 1.4k 1.6× 374 0.6× 230 5.6k
Christine Godfrey United Kingdom 37 1.9k 1.4× 1.8k 1.5× 742 0.6× 495 0.5× 346 0.6× 138 4.5k
Dennis McCarty United States 45 3.5k 2.5× 2.6k 2.2× 2.8k 2.4× 554 0.6× 696 1.2× 242 6.7k
Thomas Clausen Norway 31 1.5k 1.1× 618 0.5× 1.6k 1.4× 205 0.2× 341 0.6× 174 3.8k
Mohammed U. Kabeto United States 39 1.2k 0.8× 1.5k 1.3× 577 0.5× 886 1.0× 245 0.4× 88 5.9k
Juan J. Llibre Rodríguez Cuba 40 846 0.6× 1.1k 0.9× 1000 0.9× 1.4k 1.5× 222 0.4× 148 5.9k

Countries citing papers authored by Tami L. Mark

Since Specialization
Citations

This map shows the geographic impact of Tami L. Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tami L. Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tami L. Mark more than expected).

Fields of papers citing papers by Tami L. Mark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tami L. Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tami L. Mark. The network helps show where Tami L. Mark may publish in the future.

Co-authorship network of co-authors of Tami L. Mark

This figure shows the co-authorship network connecting the top 25 collaborators of Tami L. Mark. A scholar is included among the top collaborators of Tami L. Mark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tami L. Mark. Tami L. Mark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mark, Tami L., et al.. (2026). Opioid Treatment Programs’ Medicaid Patient Retention Rates. JAMA Network Open. 9(1). e2553538–e2553538.
2.
Mark, Tami L., Melissa Dolan, Benjamin T. Allaire, et al.. (2024). Untreated Psychiatric and Substance Use Disorders Among Caregivers With Children Reported to Child Protective Services. JAMA Health Forum. 5(4). e240637–e240637. 6 indexed citations
3.
Mark, Tami L., Melissa Dolan, Benjamin T. Allaire, et al.. (2024). Linked Child Welfare and Medicaid Data in Kentucky and Florida Highlights Racial Disparities in Access to Care. Child Maltreatment. 30(1). 3–8. 2 indexed citations
4.
Mark, Tami L.. (2023). The United States must improve its data infrastructure to ensure high-quality mental health care. Frontiers in Health Services. 3. 1059049–1059049. 1 indexed citations
5.
Parish, William J., et al.. (2022). Substance Use Disorders Among Medicare Beneficiaries: Prevalence, Mental and Physical Comorbidities, and Treatment Barriers. American Journal of Preventive Medicine. 63(2). 225–232. 22 indexed citations
6.
Mark, Tami L., et al.. (2021). Is implementation of ASAM-based addiction treatment assessments associated with improved 30-day retention and substance use?. Drug and Alcohol Dependence. 226. 108868–108868. 4 indexed citations
7.
Parish, William J., Tami L. Mark, Gary A. Zarkin, & Ellen Weber. (2021). The association of Medicare Part D prior authorization for buprenorphine–naloxone with adherence to opioid use disorder treatment guidelines in the United States. Addiction. 117(1). 141–150. 5 indexed citations
8.
Mark, Tami L., et al.. (2021). Development, Testing, and Dissemination of a Public-Facing Tool to Help Consumers Find Higher-Quality Addiction Treatment. Psychiatric Services. 73(3). 293–298. 6 indexed citations
9.
10.
Mark, Tami L., Jesse M. Hinde, Gary A. Zarkin, William J. Parish, & Marianne Kluckman. (2020). Adherence to buprenorphine treatment guidelines among individuals with an opioid use disorder who have private insurance. Journal of Substance Abuse Treatment. 116. 108062–108062. 9 indexed citations
11.
12.
Mark, Tami L. & Rita Vandivort-Warren. (2012). Spending trends on substance abuse treatment under private employer-sponsored insurance, 2001–2009. Drug and Alcohol Dependence. 125(3). 203–207. 3 indexed citations
13.
Mark, Tami L., Leslie Montejano, Henry R. Kranzler, Mady Chalk, & David R. Gastfriend. (2010). Comparison of healthcare utilization among patients treated with alcoholism medications.. PubMed. 16(12). 879–88. 23 indexed citations
14.
Mark, Tami L., Vijay N. Joish, Joel W. Hay, et al.. (2010). Antidepressant Use in Geriatric Populations: The Burden of Side Effects and Interactions and Their Impact on Adherence and Costs. American Journal of Geriatric Psychiatry. 19(3). 211–221. 57 indexed citations
15.
Mark, Tami L., Rita Vandivort-Warren, Pamela L Owens, et al.. (2010). Psychiatric Discharges in Community Hospitals With and Without Psychiatric Units: How Many and for Whom?. Psychiatric Services. 61(6). 562–568. 7 indexed citations
16.
Gibson, Teresa B., Tami L. Mark, Kirsten Axelsen, et al.. (2006). Impact of statin copayments on adherence and medical care utilization and expenditures.. PubMed. 12 Spec no.. SP11–9. 84 indexed citations
17.
18.
Mark, Tami L., Rita Vandivort-Warren, & Leslie Montejano. (2006). Factors affecting detoxification readmission: Analysis of public sector data from three states. Journal of Substance Abuse Treatment. 31(4). 439–445. 53 indexed citations
19.
Mark, Tami L.. (2001). The economic costs of heroin addiction in the United States. Drug and Alcohol Dependence. 61(2). 195–206. 223 indexed citations
20.
Mark, Tami L.. (1996). Psychiatric Hospital Ownership and Performance: Do Nonprofit Organizations Offer Advantages in Markets Characterized by Asymmetric Information?. SSRN Electronic Journal. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen E. Lasser Breakdown of academic impact, for papers by Julie M. Donohue Breakdown of academic impact, for papers by Teresa J. Hudson Breakdown of academic impact, for papers by Yuhua Bao Breakdown of academic impact, for papers by William B. Weeks Breakdown of academic impact, for papers by Christine Godfrey Breakdown of academic impact, for papers by Dennis McCarty Breakdown of academic impact, for papers by Thomas Clausen Breakdown of academic impact, for papers by Mohammed U. Kabeto Breakdown of academic impact, for papers by Juan J. Llibre Rodríguez
Rankless by CCL
2026